Article

Atogepant (Qulipta®) for migraine prevention

Trends in Pharmacological Sciences
DOI: 10.1016/j.tips.2022.03.013
2Citations
Citations of this article
27Readers
Mendeley users who have this article in their library.
Get full text

Cite

CITATION STYLE

APA

Hay, D. L., Walker, C. S., & Harris, P. W. R. (2022, August 1). Atogepant (Qulipta®) for migraine prevention. Trends in Pharmacological Sciences. Elsevier Ltd. https://doi.org/10.1016/j.tips.2022.03.013

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free